Research records indexed for Ipamorelin
This page carries 12 of the 63 records that the literature query returned for Ipamorelin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 51 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Ipamorelin.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus pmid:38996787 | 2024 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Animals" with no rodent species heading. subject headings: Testis; Hypothalamo-Hypophyseal System; Tilapia; Testosterone; Oligopeptides. |
| The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism pmid:39043357 | 2024 | Research Support, Non-U.S. Gov't | other | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Animals" with no rodent species heading. subject headings: Ileum; Ferrets; Weight Loss; Vomiting; Cisplatin. |
| Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin pmid:25869809 | 2015 | Research Support, Non-U.S. Gov't, Validation Study | other | Not stated | Indexed as research support, non-u.s. gov't, validation study. study model from MeSH "Humans" with no interventional publication type. subject headings: Oligopeptides; Urinalysis; Chromatography, Liquid; Administration, Intranasal; Substance Abuse Detection. |
| Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients pmid:25331030 | 2014 | Clinical Trial, Phase II, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, phase ii, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial, phase ii". subject headings: Intestines; Ileus; Postoperative Complications; Nausea; Vomiting. |
| Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus pmid:19289567 | 2009 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Rats, Sprague-Dawley; Ileus; Disease Models, Animal; Postoperative Complications; Body Weight. |
| Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats pmid:15665799 | 2004 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Islets Of Langerhans; Rats, Wistar; Diabetes Mellitus, Experimental; Propranolol; Yohimbine. |
| Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro pmid:12168778 | 2002 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Rats, Wistar; Body Weight; Growth Hormone; Oligopeptides; Immunoblotting. |
| Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin pmid:11459660 | 2001 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Pituitary Gland; Cells, Cultured; Swine; Indoles; Spiro Compounds. |
| The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats pmid:11735244 | 2001 | Comparative Study, Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as comparative study, research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Muscle, Skeletal; Rats, Wistar; Methylprednisolone; Hormones; Oligopeptides. |
| The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats pmid:10828840 | 2000 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Tibia; Lumbar Vertebrae; Rats, Sprague-Dawley; Body Weight; Hormones. |
| Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers pmid:10496658 | 1999 | Clinical Trial, Randomized Controlled Trial | human trial | Not stated | Indexed as clinical trial, randomized controlled trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Hormones; Human Growth Hormone; Oligopeptides; Injections, Intravenous; Predictive Value Of Tests. |
| Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats pmid:10373343 | 1999 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Bone And Bones; Rats, Sprague-Dawley; Body Weight; Hormones; Oligopeptides. |
Where this page sits
Compound page: Ipamorelin. Class: Growth hormone secretagogues.
Retrieved 2026-10-10.
Sources
- PubChem Compound Summary for CID 9831659, Ipamorelin. PubChem, National Library of Medicine (2026). pubchem:9831659
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:ipamorelin
- Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol (1998). pmid:9849822
- A new series of highly potent growth hormone-releasing peptides derived from ipamorelin. J Med Chem (1998). pmid:9733495
- Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus. J Pharmacol Exp Ther (2009). pmid:19289567
- Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis (2014). pmid:25331030
- Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. Drug Test Anal (2015). pmid:25869809
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.